(2021) Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary. Clinical Case Reports.
![]() |
Text
Clinical Case Reports - 2022 - Bidaki - Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid.pdf Download (129kB) |
Abstract
In the following, we report a therapeutic challenge faced by reduction in corticosteroid therapeutic dosage in a patient diagnosed with Hashimoto's encephalopathy (HE), which is equivalent to corticosteroid-responsive encephalopathy related to autoimmune thyroiditis and often misdiagnosed as neuropsychiatric status. The patient developed psychiatric symptoms. © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Item Type: | Article |
---|---|
Keywords: | alanine aminotransferase; aspartate aminotransferase; corticosteroid; escitalopram; levothyroxine; melatonin; methylprednisolone; pantoprazole; prednisolone; thyroglobulin antibody; thyroid antibody; vitamin D, adult; Article; autoimmune thyroiditis; Beck Depression Inventory; case report; catatonia; clinical article; electroconvulsive therapy; electroencephalography; female; free thyroxine index; human; mental disease; neuropsychiatric inventory; nuclear magnetic resonance imaging; sleep disorder; slurred speech; thyroid disease; thyroid function; thyroiditis; thyrotoxicosis |
Journal or Publication Title: | Clinical Case Reports |
Volume: | 9 |
Number: | 12 |
Depositing User: | ms soheila Bazm |
URI: | http://eprints.ssu.ac.ir/id/eprint/11674 |
Actions (login required)
![]() |
View Item |